The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences
SCImago Journal Rank (SJR) 2015: 0.518
Source Normalized Impact per Paper (SNIP) 2015: 0.897
Impact per Publication (IPP) 2015: 1.520
The Journal publishes Original Papers, Review Articles and Clinical Reports on research relating to the toxicity of chemicals and their mixtures at molecular, cellular, tissue, target organ and whole body level in vivo (by all routes of exposure) and in vitro/ex vivo. Focus is on all aspects of modern toxicology: studies of pharmacotoxicological and metabolic mechanisms, toxicogenomics and proteomics, pharmacokinetics, cytotoxicity, immunotoxicity, organ toxicity, developmental toxicity, carcinogenesis, mutagenesis, environmental toxicity and environmental health concerning humans (including epidemiological studies), predictive toxicology, risk assessment, environmental chemistry of pesticides and dioxins,forensic toxicology and alternative toxicity testing.
Aims and Scope
Why subscribe and read
- The journal aims to provide the complete and reliable source of information on current developments in the field of toxicology and related disciplines.
The emphasis is on publishing quality articles rapidly and making them freely available to researchers worldwide. All published articles will be deposited immediately upon publication in widely and internationally recognized open access repository free of charge.
- DE GRUYTER OPEN
- Type of Publication:
Submission of Manuscripts
Instructions for Authors
Interdisciplinary Toxicology (iTox) publishes quarterly and is devoted to the publication of research results in all areas of Toxicology and related scientific disciplines: /science/toxicology/itox/authors/scope/.
The primary mission of iTox is to assist Central and Eastern European researchers in communicating their achievements to the global scientific community, nevertheless, contributions from other regions of the world are by no means excluded. The journal is peer-reviewed, in electronic-only format. The language of the journal is English.
Manuscripts preferred for publication in iTox are those which:
- Contain original work - which is not published elsewhere in any medium by the authors or anyone else,
and is not under consideration for publication in any other medium. This restriction does not apply to review
- Are focused on the core aims and scope of the journal - iTox is a scientific journal publishing fundamental
research results from all fields of toxicology and related scientific disciplines.
- Are clearly and correctly written - should contain all essential features of a complete scientific paper,
should be written in a clear, easy to understand manner, and be readable for a wide audience.
- Are written in English - should be clearly and grammatically written, in an easily readable style. Attention
to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper
(Please note that authors who are not native-speakers of English can be provided with help in rewriting their
contribution in correct English)
- Are delivered in electronic format
Manuscripts should be submitted via e-mail directly to the Managing Editor of Interdisciplinary Toxicology
(Mojmír Mach, PhD.) at email@example.com).
iTox publishes research articles, communications, review papers and book reviews.
a) Research Articles
b) Rapid Communications – short reports on new and exciting results of high urgency. Sending us a
report of significant interest, authors are asked to provide an explanation in their cover letter describing
in detail why their contribution should be handled via rapid channel
c) Reviews – topical mini(reviews) as well as full critical reviews on important subjects reflecting new
trends in chemistry are also included in this section
d) Book reviews
PEER REVIEW PROCESS
All manuscripts sent via e-mail receive individual identification codes. The Managing Editor then sends it to an
appropriate Editor. However a submission may be declined by the Managing Editor without review, if deemed inappropriate
for reasons other than scientific merit.
a) choice of reviewers
The Editors of iTox, each responsible for different area of Toxicology, seek advice from experts of in the
appropriate field. Research articles and communications are reviewed by a minimum of two reviewers,
review papers by at least three.
b) suggestions from authors
Authors are requested to suggest persons competent to review their manuscript. However please note
that this will be treated only as a suggestion, and the final selection of reviewers is exclusively the Editor’s
The Editors are fully responsible for decisions about manuscripts. The final decision whether to accept or reject a
paper rests with them. The Managing Editor only communicates the final decision, and informs the authors about
REVISED MANUSCRIPT SUBMISSION
When revision of a manuscript is requested, authors should return the revised version of their manuscript as soon
as possible. Prompt action may ensure fast publication if a paper is finally accepted for publication in iTox. If it is the
first revision of an article authors need to return their revised manuscript within 60 days. If it is the second revision
authors need to return their revised manuscript within 14 days. If these deadlines are not met, and no specific
arrangements for completion have been made with the Editor, the manuscript will be treated as a new one and will
receive a new identification code along with a new registration date.
Authors will receive a pdf file with the edited version of their manuscript for final proofreading. This is the last
opportunity to view an article before its publication on the journal web site. No changes or modifications can be
introduced once it is published. Thus authors are requested to check their proof pages carefully against manuscript
within 3 working days and prepare a separate document containing all changes that should be introduced. Authors
are sometimes asked to provide additional comments and explanations in response to remarks and queries from
the language or technical editors.
ONLINE FIRST SERVICE
Manuscripts accepted for publication are published on-line in so called Online First service as soon as they are ready
for publication (that is when final proofreading is performed by authors, and all concerns are resolved). Final manuscripts
for publication may appear on the Web 1-2 months prior to regular issue publication. Once a manuscript
appears on the Web site it is considered as published.
After publication, the corresponding author is notified by email, and receives a pdf file with the published version
of the manuscript.
If any errors are detected in the published material they should be reported to the Managing Editor. The corresponding
authors should send appropriate corrected material to the Managing Editor via email. This material will
be considered for publication in the earliest available issue of iTox.
TRANSFER OF COPYRIGHT AGREEMENT
A properly completed Transfer of Copyright Agreement must be provided for each submitted manuscript. Transfer of Copyrights Agreement should be signed, scanned and sent via email to the Managing Editor of the
journal. Please read the terms of this agreement, print and then fll, sign and send a scanned document by email to
the Managing Editor of this journal.
Abstracting & Indexing
Interdisciplinary Toxicology is covered by the following services:
- Baidu Scholar
- CABI (over 50 subsections)
- Chemical Abstracts Service (CAS) - CAplus
- Chemical Abstracts Service (CAS) - SciFinder
- CNKI Scholar (China National Knowledge Infrastructure)
- DOAJ (Directory of Open Access Journals)
- EBSCO (relevant databases)
- EBSCO Discovery Service
- Elsevier - Reaxys
- Elsevier - SCOPUS
- FSTA - Food Science & Technology Abstracts
- Genamics JournalSeek
- Google Scholar
- ICAP Alcohol Information Databases
- Meta (formerly Sciencescape)
- Naviga (Softweco)
- Primo Central (ExLibris)
- ProQuest (relevant databases)
- SCImago (SJR)
- Summon (Serials Solutions/ProQuest)
- TDOne (TDNet)
- Ulrich's Periodicals Directory/ulrichsweb
- WorldCat (OCLC)
Michal Dubovický Dúbravská cesta 9, 841 04 Bratislava, Slovakia
Editorial Advisory Board
Arturo R. Anadon, Spain
Radomír Nosáľ, Slovakia
Russel J. Reiter, USA
Christina Ruden, Sweden
Marie Stiborová, Czech Republic
Aristidis M. Tsatsakis, Greece
Martin F. Wilks, Switzerland
General Toxicology, Pharmacology & Physiology
Viktor Bauer, Slovakia
Iveta Bernátová, Slovakia
Felix Carvalho, Portugal
Nancy Claude, France
Robert D. Grubbs, USA
Jaroslav Květina, Czech Republic
Gabriela Nosáľová, Slovakia
Thomas Weiser, Switzerland
Michal Zeman, Slovakia
Heidi Foth, Germany
Jyrki Liesivuori, Finland
Zdeňka Svobodová, Czech Republic
Carcinogenesis & Xenobiochemistry
Pavel Anzenbacher, Czech Republic
David R. Cool, USA
Eva Horváthová, Slovakia
Jana Navarová, Slovakia
Ladislav Šoltés, Slovakia
Jan Vondráček, Czech Republic
In Vitro Toxicology
Štefan Bezek, Slovakia
Helena Kandarova, USA
Miguel A. Sogorb, Spain
Miloň Tichý, Czech Republic
James B. Lucot, USA
Jiří Kassa, Czech Republic
Ahmet Korkmaz, Turkey
Eva Cecilie Bonefeld-Jørgensen, Denmark
Ingrid Brucknerová, Slovakia
Peter G. Fedor-Freybergh, Slovakia
Eduard Ujházy, Slovakia
Magda Kouřilová, Slovakia
Mojmir Mach, Slovakia
DE GRUYTER OPEN
Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland